Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruo-Jing Li

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
ACS Medicinal Chemistry Letters|June 20, 2020
Design and Synthesis of Tetrazole- and Pyridine-Containing Itraconazole Analogs as Potent Angiogenesis InhibitorsYingjun Li, Kalyan Kumar Pasunooti, Hanjing Peng, et al.
The AAPS Journal|January 18, 2023
Model-Informed Approach Supporting Approval of Nexviazyme (Avalglucosidase Alfa-ngpt) in Pediatric Patients with Late-Onset Pompe DiseaseRuo-Jing Li, Lian Ma, Katarzyna Drozda, et al.
Biomaterials|May 10, 2011
The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cellsXiao-Xing Wang, Yang-Bing Li, Hong-Juan Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2016
Divergence of Antiangiogenic Activity and Hepatotoxicity of Different Stereoisomers of ItraconazoleJoong Sup Shim, Ruo-Jing Li, Namandje N Bumpus, et al.
Zoological Research|January 6, 2026
Host immune constraints delineate the window of microbial colonization during early development of <i>Larimichthys crocea</i>Ruo-Jing Li, Zhen-Jun Zhuang, Zhao-Qiu Qu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2010
Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing ratsWei Tian, Xue Ying, Ju Du, et al.
ACS Chemical Biology|January 21, 2017
Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of mTOR Signaling and AngiogenesisSarah A Head, Wei Q Shi, Eun Ju Yang, et al.
Biomaterials|October 11, 2011
Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cellsLiang Zhang, Hong-Juan Yao, Yang Yu, et al.
The Oncologist|June 16, 2021
FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell LymphomaYvette L Kasamon, Lauren S L Price, Olanrewaju O Okusanya, et al.
Biomaterials|December 6, 2011
Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanomaYang Yu, Zhao-Hui Wang, Liang Zhang, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
ACS Medicinal Chemistry Letters|June 20, 2020
Design and Synthesis of Tetrazole- and Pyridine-Containing Itraconazole Analogs as Potent Angiogenesis InhibitorsYingjun Li, Kalyan Kumar Pasunooti, Hanjing Peng, et al.
The AAPS Journal|January 18, 2023
Model-Informed Approach Supporting Approval of Nexviazyme (Avalglucosidase Alfa-ngpt) in Pediatric Patients with Late-Onset Pompe DiseaseRuo-Jing Li, Lian Ma, Katarzyna Drozda, et al.
Biomaterials|May 10, 2011
The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cellsXiao-Xing Wang, Yang-Bing Li, Hong-Juan Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2016
Divergence of Antiangiogenic Activity and Hepatotoxicity of Different Stereoisomers of ItraconazoleJoong Sup Shim, Ruo-Jing Li, Namandje N Bumpus, et al.
Zoological Research|January 6, 2026
Host immune constraints delineate the window of microbial colonization during early development of <i>Larimichthys crocea</i>Ruo-Jing Li, Zhen-Jun Zhuang, Zhao-Qiu Qu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 6, 2010
Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing ratsWei Tian, Xue Ying, Ju Du, et al.
ACS Chemical Biology|January 21, 2017
Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of mTOR Signaling and AngiogenesisSarah A Head, Wei Q Shi, Eun Ju Yang, et al.
Biomaterials|October 11, 2011
Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cellsLiang Zhang, Hong-Juan Yao, Yang Yu, et al.
The Oncologist|June 16, 2021
FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell LymphomaYvette L Kasamon, Lauren S L Price, Olanrewaju O Okusanya, et al.
Biomaterials|December 6, 2011
Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanomaYang Yu, Zhao-Hui Wang, Liang Zhang, et al.
Pageof 4